07.03.2017 21:15:00
|
DaVita Celebrates 10 Consecutive Years Among FORTUNE® Magazine's World's Most Admired Companies®
DENVER, March 7, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced has been recognized as one of FORTUNE Magazine's World's Most Admired Companies in 2017. This is the 10th consecutive year and 11th year overall the company has appeared on the list.
In addition to being named to the list, DaVita ranked first in Quality of Products/Services in the health care medical facilities category.
"Building a company with an award-winning culture starts with a commitment to community," said Kent Thiry, chairman and CEO of DaVita. "Our teammates' dedication to making DaVita a special place translates to exceptional quality care for our patients."
DaVita Kidney Care is the recognized clinical leader according to two government reports, the Centers for Medicare and Medicaid Services' (CMS) Quality Incentive Program and Five-Star Quality Star Rating System. For the third year in a row, DaVita outperformed other major dialysis providers in the Quality Incentive Program and outperformed the industry in the Five-Star Quality Rating System.
FORTUNE surveys company executives, board members and industry analysts to compile its rankings. Other factors include people management, use of corporate assets, quality of management, financial soundness, long-term investment and global competitiveness.
Learn how DaVita's award-winning culture helps deliver quality patient care at DaVita.com/CSR.
About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners, a DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of September 30, 2016, DaVita Kidney Care operated or provided administrative services at 2,318 outpatient dialysis centers located in the United States serving approximately 186,000 patients. The company also operated 139 outpatient dialysis centers located in 11 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in California, Nevada, New Mexico, Florida, Colorado and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of September 30, 2016 HealthCare Partners provided integrated care management for approximately 750,000 patients. For more information, please visit DaVita.com/about.
First appearance of licensed trademarks in all licensed uses must be followed immediately by the ® symbol for registered trademarks. Licensed trademarks must appear with a conspicuous trademark notice as follows: "FORTUNE and The World's Most Admired Companies are registered trademarks of Time Inc. and are used under license."
From FORTUNE Magazine, March 1, 2017 ©2017 Time Inc. Used under license. FORTUNE and Time Inc. are not affiliated with, and do not endorse products or services of, Licensee.
Contact Information
Media:
Caitlyn Shuket
(303) 876-7547
Caitlyn.Shuket@davita.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-celebrates-10-consecutive-years-among-fortune-magazines-worlds-most-admired-companies-300419661.html
SOURCE DaVita Inc.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DaVita HealthCare Partners Incmehr Nachrichten
14.02.25 |
NYSE-Handel: S&P 500 klettert (finanzen.at) | |
14.02.25 |
S&P 500-Handel aktuell: S&P 500 in der Gewinnzone (finanzen.at) | |
14.02.25 |
Zuversicht in New York: S&P 500 beginnt Sitzung mit Gewinnen (finanzen.at) | |
14.02.25 |
AKTIE IM FOKUS 2: FMC schwach - Davita überzeugt nicht, Hohe Sterblichkeit (dpa-AFX) | |
12.02.25 |
Ausblick: DaVita HealthCare Partners legt Quartalsergebnis vor (finanzen.net) | |
10.02.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel Gewinn hätte eine DaVita HealthCare Partners-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
03.02.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel Gewinn hätte ein Investment in DaVita HealthCare Partners von vor einem Jahr abgeworfen (finanzen.at) | |
27.01.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel hätten Anleger an einem DaVita HealthCare Partners-Investment von vor 10 Jahren verdient (finanzen.at) |
Analysen zu DaVita HealthCare Partners Incmehr Analysen
Aktien in diesem Artikel
DaVita HealthCare Partners Inc | 148,30 | -12,46% |
|